Skip to Main Content

Paper Details

The Coming of Age of Nucleic Acid Vaccines during COVID-19.
mSystems
5
2023
COVID, COVID-19, COVID-19 crisis, DNA, RNA sequence, SARS, SARS-, SARS-CoV, SARS-CoV-2, coronavirus, humans, nucleic acid, severe acute respiratory syndrome coronavirus 2
COVID-19, COVID-19 Vaccines, Humans, Nucleic Acid-Based Vaccines, Pandemics, SARS-CoV-2, Viral Vaccines, mRNA Vaccines
Author NameAffiliation
Halie M RandoUniversity of Pennsylvania
Halie M RandoUniversity of Colorado Anschutz School of Medicine
Halie M RandoCenter for Health AI, University of Colorado Anschutz School of Medicine
Halie M RandoUniversity of Colorado Anschutz School of Medicine
Ronan LordanUniversity of Pennsylvania
Ronan LordanInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania
Ronan LordanPerelman School of Medicine, University of Pennsylvania
Likhitha KollaPerelman School of Medicine, University of Pennsylvania
Elizabeth SellPerelman School of Medicine, University of Pennsylvania
Alexandra J LeeUniversity of Pennsylvania
Alexandra J LeeUniversity of Pennsylvania
Nils WellhausenUniversity of Pennsylvania
Amruta NaikChildren's Hospital of Philadelphia
Jeremy P KamilLouisiana State University Health Sciences Center Shreveport
Anthony GitterUniversity of Wisconsin-Madison
Anthony GitterMorgridge Institute for Research
Casey S GreeneUniversity of Pennsylvania
Casey S GreeneUniversity of Colorado Anschutz School of Medicine
Casey S GreeneCenter for Health AI, University of Colorado Anschutz School of Medicine
Casey S GreeneUniversity of Colorado Anschutz School of Medicine
Casey S GreeneAlex's Lemonade Stand Foundation
Casey S GreeneUniversity of Pennsylvania
Casey S GreeneUniversity of Colorado Anschutz School of Medicine
Casey S GreeneCenter for Health AI, University of Colorado Anschutz School of Medicine
Casey S GreeneUniversity of Colorado Anschutz School of Medicine
Casey S GreeneAlex's Lemonade Stand Foundation
  • 1 - 26

Datasets

Release 1.2